Status:
COMPLETED
Treatment of Bacterial Vaginosis With Oral Tinidazole
Lead Sponsor:
Mission Pharmacal
Conditions:
Bacterial Vaginosis
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to confirm the safety and efficacy of oral tinidazole for the treatment of bacterial vaginosis.
Detailed Description
Tinidazole is a second-generation nitroimidazole i.e. an updated form of the standard drug used to treat bacterial vaginosis (metronidazole). Two dosing regimens are being compared to placebo to treat...
Eligibility Criteria
Inclusion
- Clinical and microbiological diagnosis of bacterial vaginosis -
Exclusion
- Other sexually transmitted disease
- \-
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00229216
Start Date
January 1 2005
End Date
June 1 2007
Last Update
March 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University School of Medicine
Durham, North Carolina, United States, 27710